---
keywords:
  - Foundation Models
  - Convolutional Neural Networks
  - Fourier Domain Adaptation
category: cs.AI
publish_date: 2025-09-19
arxiv_id: 2509.02591
---

<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-22 21:46:11.407767",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Foundation Models",
    "Convolutional Neural Networks",
    "Fourier Domain Adaptation"
  ],
  "rejected_keywords": [
    "Mitotic Figures"
  ],
  "similarity_scores": {
    "Foundation Models": 0.8,
    "Convolutional Neural Networks": 0.78,
    "Fourier Domain Adaptation": 0.75
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true
}
-->


# Ensemble of Pathology Foundation Models for MIDOG 2025 Track 2: Atypical Mitosis Classification

**Korean Title:** ë³‘ë¦¬í•™ ê¸°ì´ˆ ëª¨ë¸ ì•™ìƒë¸”ì„ í™œìš©í•œ MIDOG 2025 íŠ¸ë™ 2: ë¹„ì •í˜• ìœ ì‚¬ë¶„ì—´ ë¶„ë¥˜

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[digests/daily_digest_20250919|2025-09-19]]   [[categories/cs.AI|cs.AI]]

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ”— Specific Connectable**: [[keywords/Convolutional Neural Networks|Convolutional Neural Network]]
**âš¡ Unique Technical**: [[keywords/Fourier Domain Adaptation|Fourier Domain Adaptation]]
**ğŸš€ Evolved Concepts**: [[keywords/Foundation Models|Pathology Foundation Models]]

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[Generative_AI_for_Misalignment-Resistant_Virtual_Staining_to_Accelerate_Histopathology_Workflows_20250918|Generative AI for Misalignment-Resistant Virtual Staining to Accelerate Histopathology Workflows]] (81.3% similar)
- [[Taylor-Series_Expanded_Kolmogorov-Arnold_Network_for_Medical_Imaging_Classification_20250918|Taylor-Series Expanded Kolmogorov-Arnold Network for Medical Imaging Classification]] (80.8% similar)
- [[Superpose_Task-specific_Features_for_Model_Merging_20250919|Superpose Task-specific Features for Model Merging]] (80.7% similar)
- [[Fine-tuning_Vision_Language_Models_with_Graph-based_Knowledge_for_Explainable_Medical_Image_Analysis_20250919|Fine-tuning Vision Language Models with Graph-based Knowledge for Explainable Medical Image Analysis]] (80.4% similar)
- [[ModalSurv A Multimodal Deep Survival Framework for Prostate and Bladder Cancer]] (80.2% similar)

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.02591v3 Announce Type: replace-cross 
Abstract: Mitotic figures are classified into typical and atypical variants, with atypical counts correlating strongly with tumor aggressiveness. Accurate differentiation is therefore essential for patient prognostication and resource allocation, yet remains challenging even for expert pathologists. Here, we leveraged Pathology Foundation Models (PFMs) pre-trained on large histopathology datasets and applied parameter-efficient fine-tuning via low-rank adaptation. In addition, we incorporated ConvNeXt V2, a state-of-the-art convolutional neural network architecture, to complement PFMs. During training, we employed a fisheye transform to emphasize mitoses and Fourier Domain Adaptation using ImageNet target images. Finally, we ensembled multiple PFMs to integrate complementary morphological insights, achieving competitive balanced accuracy on the Preliminary Evaluation Phase dataset.

## ğŸ” Abstract (í•œê¸€ ë²ˆì—­)

arXiv:2509.02591v3 ë°œí‘œ ìœ í˜•: êµì°¨ êµì²´  
ì´ˆë¡: ìœ ì‚¬ ë¶„ì—´ ìƒì€ ì „í˜•ì  ë° ë¹„ì „í˜•ì  ë³€ì¢…ìœ¼ë¡œ ë¶„ë¥˜ë˜ë©°, ë¹„ì „í˜•ì  ìˆ˜ì¹˜ëŠ” ì¢…ì–‘ì˜ ê³µê²©ì„±ê³¼ ê°•í•˜ê²Œ ìƒê´€ê´€ê³„ê°€ ìˆìŠµë‹ˆë‹¤. ë”°ë¼ì„œ ì •í™•í•œ êµ¬ë¶„ì€ í™˜ìì˜ ì˜ˆí›„ í‰ê°€ì™€ ìì› í• ë‹¹ì— í•„ìˆ˜ì ì´ì§€ë§Œ, ì „ë¬¸ê°€ ë³‘ë¦¬í•™ìì—ê²Œë„ ì—¬ì „íˆ ì–´ë ¤ìš´ ê³¼ì œì…ë‹ˆë‹¤. ë³¸ ì—°êµ¬ì—ì„œëŠ” ëŒ€ê·œëª¨ ì¡°ì§ë³‘ë¦¬ ë°ì´í„°ì…‹ìœ¼ë¡œ ì‚¬ì „ í•™ìŠµëœ ë³‘ë¦¬í•™ ê¸°ì´ˆ ëª¨ë¸(Pathology Foundation Models, PFMs)ì„ í™œìš©í•˜ê³ , ì €ìˆœìœ„ ì ì‘ì„ í†µí•œ íŒŒë¼ë¯¸í„° íš¨ìœ¨ì  ë¯¸ì„¸ ì¡°ì •ì„ ì ìš©í–ˆìŠµë‹ˆë‹¤. ë˜í•œ, PFMsë¥¼ ë³´ì™„í•˜ê¸° ìœ„í•´ ìµœì²¨ë‹¨ í•©ì„±ê³± ì‹ ê²½ë§ êµ¬ì¡°ì¸ ConvNeXt V2ë¥¼ ë„ì…í–ˆìŠµë‹ˆë‹¤. í›ˆë ¨ ê³¼ì •ì—ì„œ ìš°ë¦¬ëŠ” ìœ ì‚¬ ë¶„ì—´ì„ ê°•ì¡°í•˜ê¸° ìœ„í•´ ì–´ì•ˆ ë³€í™˜ì„ ì‚¬ìš©í•˜ê³ , ImageNet ëª©í‘œ ì´ë¯¸ì§€ë¥¼ ì‚¬ìš©í•œ í‘¸ë¦¬ì— ë„ë©”ì¸ ì ì‘ì„ ì ìš©í–ˆìŠµë‹ˆë‹¤. ë§ˆì§€ë§‰ìœ¼ë¡œ, ì—¬ëŸ¬ PFMsë¥¼ ì•™ìƒë¸”í•˜ì—¬ ìƒí˜¸ ë³´ì™„ì ì¸ í˜•íƒœí•™ì  í†µì°°ì„ í†µí•©í•˜ì—¬ ì˜ˆë¹„ í‰ê°€ ë‹¨ê³„ ë°ì´í„°ì…‹ì—ì„œ ê²½ìŸë ¥ ìˆëŠ” ê· í˜• ì •í™•ë„ë¥¼ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤.

## ğŸ“ ìš”ì•½

ì´ ë…¼ë¬¸ì€ ì „í˜•ì  ë° ë¹„ì „í˜•ì  ìœ ì‚¬ë¶„ì—´ì„ ë¶„ë¥˜í•˜ëŠ” ë°©ë²•ì„ ì œì•ˆí•©ë‹ˆë‹¤. ë¹„ì „í˜•ì  ìœ ì‚¬ë¶„ì—´ì€ ì¢…ì–‘ì˜ ê³µê²©ì„±ê³¼ ê°•í•˜ê²Œ ì—°ê´€ë˜ì–´ ìˆì–´ ì •í™•í•œ ë¶„ë¥˜ê°€ ì¤‘ìš”í•©ë‹ˆë‹¤. ì—°êµ¬ì§„ì€ ëŒ€ê·œëª¨ ë³‘ë¦¬í•™ ë°ì´í„°ì…‹ìœ¼ë¡œ ì‚¬ì „ í•™ìŠµëœ ë³‘ë¦¬í•™ ê¸°ì´ˆ ëª¨ë¸(PFMs)ì„ í™œìš©í•˜ê³ , ì €ë­í¬ ì ì‘ì„ í†µí•œ íš¨ìœ¨ì ì¸ ë¯¸ì„¸ ì¡°ì •ì„ ì ìš©í–ˆìŠµë‹ˆë‹¤. ë˜í•œ, ìµœì‹  ì»¨ë³¼ë£¨ì…˜ ì‹ ê²½ë§ êµ¬ì¡°ì¸ ConvNeXt V2ë¥¼ ì‚¬ìš©í•˜ì—¬ PFMsë¥¼ ë³´ì™„í–ˆìŠµë‹ˆë‹¤. í•™ìŠµ ê³¼ì •ì—ì„œ ìœ ì‚¬ë¶„ì—´ì„ ê°•ì¡°í•˜ê¸° ìœ„í•´ ì–´ì•ˆ ë³€í™˜ê³¼ ImageNet íƒ€ê²Ÿ ì´ë¯¸ì§€ë¥¼ ì‚¬ìš©í•œ í‘¸ë¦¬ì— ë„ë©”ì¸ ì ì‘ì„ ì‚¬ìš©í–ˆìŠµë‹ˆë‹¤. ì—¬ëŸ¬ PFMsë¥¼ ì•™ìƒë¸”í•˜ì—¬ ë³´ì™„ì ì¸ í˜•íƒœí•™ì  í†µì°°ì„ í†µí•©í•¨ìœ¼ë¡œì¨, ì˜ˆë¹„ í‰ê°€ ë‹¨ê³„ ë°ì´í„°ì…‹ì—ì„œ ê²½ìŸë ¥ ìˆëŠ” ê· í˜• ì •í™•ë„ë¥¼ ë‹¬ì„±í–ˆìŠµë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. ë¹„ì •í˜• ìœ ì‚¬ë¶„ì—´ ìˆ˜ëŠ” ì¢…ì–‘ì˜ ê³µê²©ì„±ê³¼ ê°•í•˜ê²Œ ìƒê´€ê´€ê³„ê°€ ìˆìœ¼ë©°, ì •í™•í•œ êµ¬ë¶„ì´ í™˜ì ì˜ˆí›„ì™€ ìì› ë°°ë¶„ì— í•„ìˆ˜ì ì´ë‹¤.

- 2. ëŒ€ê·œëª¨ ë³‘ë¦¬í•™ ë°ì´í„°ì…‹ìœ¼ë¡œ ì‚¬ì „ í•™ìŠµëœ ë³‘ë¦¬í•™ ê¸°ì´ˆ ëª¨ë¸(PFMs)ì„ í™œìš©í•˜ê³ , ì €ìˆœìœ„ ì ì‘ì„ í†µí•´ ë§¤ê°œë³€ìˆ˜ íš¨ìœ¨ì ì¸ ë¯¸ì„¸ ì¡°ì •ì„ ìˆ˜í–‰í–ˆë‹¤.

- 3. ìµœì²¨ë‹¨ í•©ì„±ê³± ì‹ ê²½ë§ ì•„í‚¤í…ì²˜ì¸ ConvNeXt V2ë¥¼ PFMsì™€ ê²°í•©í•˜ì—¬ ì„±ëŠ¥ì„ ë³´ì™„í–ˆë‹¤.

- 4. í›ˆë ¨ ê³¼ì •ì—ì„œ ìœ ì‚¬ë¶„ì—´ì„ ê°•ì¡°í•˜ê¸° ìœ„í•´ ì–´ì•ˆ ë³€í™˜ê³¼ ImageNet ëŒ€ìƒ ì´ë¯¸ì§€ë¥¼ ì‚¬ìš©í•œ í‘¸ë¦¬ì— ë„ë©”ì¸ ì ì‘ì„ ì ìš©í–ˆë‹¤.

- 5. ì—¬ëŸ¬ PFMsë¥¼ ì•™ìƒë¸”í•˜ì—¬ ìƒí˜¸ ë³´ì™„ì ì¸ í˜•íƒœí•™ì  í†µì°°ì„ í†µí•©í•˜ì—¬, Preliminary Evaluation Phase ë°ì´í„°ì…‹ì—ì„œ ê²½ìŸë ¥ ìˆëŠ” ê· í˜• ì •í™•ë„ë¥¼ ë‹¬ì„±í–ˆë‹¤.

---

*Generated on 2025-09-19 15:21:14*